发明名称 1-OXOISOQUINOLINE AND PRODUCTION THEREOF
摘要 <p>PROBLEM TO BE SOLVED: To obtain the subject novel 1-oxoisoquinolines that has aldose reductase inhibitory activity and is effective for treatment of a variety of diabetic complications with cataract, retinopathy, neuropathy, nephropathy or the like. SOLUTION: This compound is represented by formula I R1-R3 are each H, a (substituted) 1-20C alkyl, a (substituted) 1-4C alkylaryl or a (substituted) aryl; R4 is H or the formula: CH2CO2R5 [R5 is H, a (substituted) 1-20C alkyl, a (substituted) 1-4C alkylaryl or the like]}, typically the compound of formula II. The compound of formula I is prepared, for example, by converting any of R1-R3 is converted to H, when necessary, or either R1 or R2 is used as a suitable protecting group for hydroxyl groups in an isocoumarin derivative and aminating the isocoumarin with ammonia or primary amines to convert to the corresponding isoquinoline derivative.</p>
申请公布号 JP2000309574(A) 申请公布日期 2000.11.07
申请号 JP19990120264 申请日期 1999.04.27
申请人 MICROBIAL CHEM RES FOUND;MERCIAN CORP 发明人 NAKAJIMA TAKASHI;ISSHIKI KUNIO;AGATA NAOKI;YOSHIOKA TAKEO;TAKEUCHI TOMIO
分类号 C07D217/24;A61K31/00;A61K31/47;A61K31/472;A61P13/00;A61P13/12;A61P25/00;A61P27/00;A61P27/02;A61P27/12;A61P43/00;(IPC1-7):C07D217/24 主分类号 C07D217/24
代理机构 代理人
主权项
地址